MACK
Merrimack Pharmaceuticals, Inc
$14.73
Earnings Summary
Revenue | $0Mn |
Net Profits | $-0.24Mn |
Net Profit Margins | -Inf% |
Highlights
Merrimack Pharmaceuticals, Inc’s revenue jumped 100% since last year same period to $0Mn in the Q4 2023. On a quarterly growth basis, Merrimack Pharmaceuticals, Inc has generated NaN% jump in its revenue since last 3-months.
Merrimack Pharmaceuticals, Inc’s net profit jumped 51.22% since last year same period to $-0.24Mn in the Q4 2023. On a quarterly growth basis, Merrimack Pharmaceuticals, Inc has generated 13.98% jump in its net profits since last 3-months.
Merrimack Pharmaceuticals, Inc’s net profit margin fell -Inf% since last year same period to -Inf% in the Q4 2023. On a quarterly growth basis, Merrimack Pharmaceuticals, Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Merrimack Pharmaceuticals, Inc post its latest quarter earnings
EPS Estimate Current Quarter | -1 |
EPS Estimate Current Year | -1 |
Highlights
Merrimack Pharmaceuticals, Inc’s earning per share (EPS) estimates for the current quarter stand at -1 - a -20.48% fall from last quarter’s estimates.
Merrimack Pharmaceuticals, Inc’s earning per share (EPS) estimates for the current year stand at -1.
Key Ratios
Key ratios of the Merrimack Pharmaceuticals, Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.02 |
Highlights
Merrimack Pharmaceuticals, Inc’s earning per share (EPS) jumped 53.22% since last year same period to -0.02 in the Q4 2023. This indicates that the Merrimack Pharmaceuticals, Inc has generated 53.22% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2019-07-17 | -0.83 | -0.67 | 19.28% |
2019-05-10 | -0.92 | -0.78 | 15.22% |
2019-11-12 | -0.83 | -0.67 | 19.28% |
2020-03-12 | -1 | -0.67 | 33% |
₹0 US Stocks a/c Opening Fee